Effects of LPS stimulation on phenotype and functions of 1, 25(OH)_2D_3-treated dendritic cells
Ying Huang
Abstract
Ying Huang
Abstract
This study designed to investigate the effects of LPS stimulation on phenotype and functions of 1,25-dihydroxyvitamin D3(1, 25(OH)2D3)-treated dendritic cells(DC) in vitro. Firstly, 1, 25(OH)2D3-treated DC(10-8mol/L) were stimulated by LPS for 24 hours. Then the morphology of DC was observed by inverted microscopy; the expression of co-stimulatory molecules(CD80, CD86, and CD40) and MHC class Ⅱ was determined by flow cytometry; the levels of IL-12p70 and IL-10 were analyzed by ELISA. Furthermore, the capability of stimulating allogeneic CD4+T cell proliferation was measured by MLR(mixed lymphocyte reaction).1, 25(OH)2D3-treated DC stimulated by LPS exhibited features of inmature DC with high expression of costimulatory molecules CD86 and MHC class Ⅱ, inhibiting the secretion of IL-12p70, enhancing the secretion of IL-10, and suppressing allogeneic CD4+T cell proliferation. Results in this study indicate that 1, 25(OH)2D3-treated DC have the character of tolerogenic DCs, which can inhibit LPS-drived proliferation of CD4+T cells, which should be a foundation for study of 1, 25(OH)2D3-treated DCs inducing immunotolerance and the treatment of autoimmune disease such as asthma.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This study designed to investigate the effects of LPS stimulation on phenotype and functions of 1,25-dihydroxyvitamin D3(1, 25(OH)2D3)-treated dendritic cells(DC) in vitro. Firstly, 1, 25(OH)2D3-treated DC(10-8mol/L) were stimulated by LPS for 24 hours. Then the morphology of DC was observed by inverted microscopy; the expression of co-stimulatory molecules(CD80, CD86, and CD40) and MHC class Ⅱ was determined by flow cytometry; the levels of IL-12p70 and IL-10 were analyzed by ELISA. Furthermore, the capability of stimulating allogeneic CD4+T cell proliferation was measured by MLR(mixed lymphocyte reaction).1, 25(OH)2D3-treated DC stimulated by LPS exhibited features of inmature DC with high expression of costimulatory molecules CD86 and MHC class Ⅱ, inhibiting the secretion of IL-12p70, enhancing the secretion of IL-10, and suppressing allogeneic CD4+T cell proliferation. Results in this study indicate that 1, 25(OH)2D3-treated DC have the character of tolerogenic DCs, which can inhibit LPS-drived proliferation of CD4+T cells, which should be a foundation for study of 1, 25(OH)2D3-treated DCs inducing immunotolerance and the treatment of autoimmune disease such as asthma.
Key concepts: CD80, CD86, Mixed lymphocyte reaction, CD40, Dendritic cell, MHC class II, Chemistry, Stimulation